Education
About Us
Working with TipRanks
Follow Us
Genix Pharmaceuticals (TSE:GENX)
:GENX
GENX Stock Chart & Stats
C$0.02
--
Market closed
C$0.02
--
Day’s Range― - ―
52-Week RangeC$0.02 - C$0.07
Previous CloseN/A
VolumeN/A
Average Volume (3M)71.47K
Market Cap
C$1.18M
Enterprise ValueC$2.80M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.45
Next Earnings
Mar 03, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding59,224,133
10 Day Avg. Volume2,600
30 Day Avg. Volume71,466
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Genix Pharmaceuticals News
GENX FAQ
What was Genix Pharmaceuticals’s price range in the past 12 months?
Genix Pharmaceuticals lowest stock price was C$0.02 and its highest was C$0.07 in the past 12 months.
What is Genix Pharmaceuticals’s market cap?
Genix Pharmaceuticals’s market cap is C$1.18M.
When is Genix Pharmaceuticals’s upcoming earnings report date?
Genix Pharmaceuticals’s upcoming earnings report date is Mar 03, 2026 which is in 70 days.
How were Genix Pharmaceuticals’s earnings last quarter?
Genix Pharmaceuticals released its earnings results on Sep 22, 2025. The company reported -C$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.001.
Is Genix Pharmaceuticals overvalued?
According to Wall Street analysts Genix Pharmaceuticals’s price is currently Overvalued.
Does Genix Pharmaceuticals pay dividends?
Genix Pharmaceuticals does not currently pay dividends.
What is Genix Pharmaceuticals’s EPS estimate?
Genix Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Genix Pharmaceuticals have?
Genix Pharmaceuticals has 59,224,133 shares outstanding.
What happened to Genix Pharmaceuticals’s price movement after its last earnings report?
Genix Pharmaceuticals reported an EPS of -C$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Genix Pharmaceuticals?
Currently, no hedge funds are holding shares in TSE:GENX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Genix Pharmaceuticals
Genix Pharmaceuticals Corp is a Canadian life sciences company engaged in the research, development, manufacturing and marketing of high growth, high margin, novel and proprietary, evidence-based, pharmaceuticals, over-the-counter products, nutraceuticals and healthcare products, as well as generic medicines.
Technical Analysis
Mydecine Innovations Group
―
ZYUS Life Sciences
―
Lumiera Health Inc
―
LSL Pharma Group Inc
―
NAVCO Pharmaceuticals Inc
―
Options Prices
Currently, No data available
---